Skip to content
10-Q

Quarterly Report

CARIS LIFE SCIENCES, INC. CAI

0002019410-26-000044

← back to feed
Filed
May 8, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · May 5, 2026 282.68M sh
Shares Diluted Q1 2026 · Mar 31, 2026 282.56M sh
Shares Diluted Q1 2026 · Mar 31, 2025 35.62M sh
Stock Repurchased Q1 2026 · Mar 31, 2026 $0
Stock Repurchased Q1 2026 · Mar 31, 2025 $22K
Capex Q1 2026 · Mar 31, 2026 $10.34M
Capex Q1 2026 · Mar 31, 2025 $2.69M
Operating Cash Flow Q1 2026 · Mar 31, 2026 $32.88M
Operating Cash Flow Q1 2026 · Mar 31, 2025 −$31.34M
Long Term Debt Q1 2026 · Mar 31, 2026 $381.4M
Long Term Debt Q1 2026 · Dec 31, 2025 $378.82M
Short Term Debt Q1 2026 · Mar 31, 2026 $173K
Short Term Debt Q1 2026 · Dec 31, 2025 $169K
Cash And Equivalents Q1 2026 · Mar 31, 2026 $819.9M
Cash And Equivalents Q1 2026 · Mar 31, 2025 $31.2M
Stockholders Equity Q1 2026 · Mar 31, 2026 $593.49M
Stockholders Equity Q1 2026 · Dec 31, 2025 $577.31M
Stockholders Equity Q1 2026 · Mar 31, 2025 −$2.6B
Stockholders Equity Q1 2026 · Dec 31, 2024 −$2.5B
Current Liabilities Q1 2026 · Mar 31, 2026 $143.9M
Current Liabilities Q1 2026 · Dec 31, 2025 $127.15M
Total Liabilities Q1 2026 · Mar 31, 2026 $568.9M
Total Liabilities Q1 2026 · Dec 31, 2025 $548.36M
Current Assets Q1 2026 · Mar 31, 2026 $1.01B
Current Assets Q1 2026 · Dec 31, 2025 $997.8M
Total Assets Q1 2026 · Mar 31, 2026 $1.16B
Total Assets Q1 2026 · Dec 31, 2025 $1.13B
Eps Diluted Q1 2026 · Mar 31, 2026 $0.00
Eps Diluted Q1 2026 · Mar 31, 2025 −$3.57
Eps Basic Q1 2026 · Mar 31, 2026 $0.00
Eps Basic Q1 2026 · Mar 31, 2025 −$3.57
Sga Expense Q1 2026 · Mar 31, 2026 $59.71M
Sga Expense Q1 2026 · Mar 31, 2025 $52.12M
Rd Expense Q1 2026 · Mar 31, 2026 $31.32M
Rd Expense Q1 2026 · Mar 31, 2025 $23.07M
Net Income Q1 2026 · Mar 31, 2026 −$510K
Net Income Q1 2026 · Mar 31, 2025 −$102.58M
Operating Income Q1 2026 · Mar 31, 2026 $5.28M
Operating Income Q1 2026 · Mar 31, 2025 −$57.95M
Revenue Q1 2026 · Mar 31, 2026 $216.17M
Revenue Q1 2026 · Mar 31, 2025 $120.92M